Bionano Genomics, Inc.

SAN DIEGO, CA How do I update this listing?

Create Email Alert

Bionano Genomics is based out of San Diego. The firm last filed a Form D notice of exempt offering of securities on 2021-10-25. The notice included securities offered of Equity

Contact Info

bionano genomics, inc.
9540 TOWNE CENTRE DRIVE
SAN DIEGO CA    92121

Business Phone: (858) 888-7600
SEC SIC CODE:
3826-LABORATORY ANALYTICAL INSTRUMENTS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2021-10-25 D OTHER HEALTH CARE Equity 41,850,386 41,850,386 0
2019-03-28 D PHARMACEUTICALS Equity 11,500,000 2,500,000 9,000,000
2015-01-27 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Other 68,443,451 68,443,451 0
2014-06-27 D PHARMACEUTICALS Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 6,139,997 5,000,500 1,139,497
2014-01-08 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 15,000 15,000 0
2013-10-02 D PHARMACEUTICALS Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 13,663,054 10,001,000 3,662,054
2012-07-05 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other 13,939,494 11,573,201 2,366,293
2011-03-24 D BIOTECHNOLOGY Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 23,265,909 23,265,909 0
2010-04-27 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 4,000,000 782,314 3,217,686
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
EDWARD L. ERICKSON subscription required
    EXECUTIVE OFFICER DIRECTOR
TRACY WARREN subscription required
    DIRECTOR
LORRAINE G. LOPRESTI subscription required
    EXECUTIVE OFFICER
ROBERT ERIK HOLMLIN subscription required
    EXECUTIVE OFFICER DIRECTOR
DAVID L. BARKER subscription required
    DIRECTOR
BRIAN HALAK subscription required
    DIRECTOR
R. ERIK HOLMLIN subscription required
    EXECUTIVE OFFICER DIRECTOR
ALBERT A. LUDERER subscription required
    DIRECTOR
HAN CAO subscription required
    EXECUTIVE OFFICER
GARTH MONROE subscription required
    EXECUTIVE OFFICER
LYNNE ROLLINS subscription required
    EXECUTIVE OFFICER
JOEL R. JUNG subscription required
    EXECUTIVE OFFICER
ERIK R. HOLMLIN subscription required
    EXECUTIVE OFFICER DIRECTOR
DARREN CAI subscription required
    DIRECTOR
CAMPBELL MURRAY subscription required
    DIRECTOR
R. ERIK HOLMLIN, PH.D. subscription required
    EXECUTIVE OFFICER DIRECTOR
MIKE WARD subscription required
    EXECUTIVE OFFICER
WARREN ROBINSON subscription required
    EXECUTIVE OFFICER
MARK BORODKIN subscription required
    EXECUTIVE OFFICER
DAVID L. BARKER, PH.D. subscription required
    DIRECTOR
DARREN CAI, PH.D. subscription required
    DIRECTOR
ALBERT LUDERER, PH.D. subscription required
    DIRECTOR
JUNFENG WANG subscription required
    DIRECTOR
CHRISTOPHER TWOMEY subscription required
    DIRECTOR
QUAN ZHOU subscription required
    DIRECTOR
MARK OLDAKOWSKI subscription required
    EXECUTIVE OFFICER
CHRISTOPHER STEWART subscription required
    EXECUTIVE OFFICER
ALKA CHAUBEY, PH.D., FACMG subscription required
    EXECUTIVE OFFICER
YVONNE LINNEY, PH.D. subscription required
    DIRECTOR
JASON PRIAR subscription required
    EXECUTIVE OFFICER
KRISTIINA VUORI, M.D., PH.D. subscription required
    DIRECTOR
HANNAH MAMUSZKA subscription required
    DIRECTOR
RICHARD SHIPPY subscription required
    EXECUTIVE OFFICER
SOHEIL SHAMS subscription required
    EXECUTIVE OFFICER

Elevate your investments